In pancreatic cancer, in addition to affecting tumor progression through the regulation of the cell cycle, USP22 can also influence tumorigenesis and development by regulating immune cell infiltration through nuclear functions independent of its effects on PD-L1 protein stability (31). This evidence concerns the gene CD274 and neoplasm.